Outsourcing

Articles

Steriline will be exhibiting its vial filling and capping machine (VFCM100) under double-wall isolator for aseptic filling at CPHI 2022 in Frankfurt, Germany, on Nov. 1–3, 2022.

Steriline Showcases Filling Equipment at CPHI 2022

Recipharm’s new high speed filling line, designed for pre-filled syringes and cartridges, is expected to be operational by May 2023.

Recipharm to Add High-Speed Filling Line to Wasserburg Facility

Meg Rivers is the former senior editor for 

Felicity Thomas is Associate Editorial Director of Pharmaceutical Technology, Pharmaceutical Technology Europe, BioPharm International.

Videos

Pharmaceutical Technology editors interview aseptic and sterilization experts from Watson-Marlow Fluid Technology Solutions and Cherwell—diving into sterilization, aseptic processing, and the revised EU GMP Annex 1 guidance.

Drug Digest: Sterilization’s Horizon: Improving Automation, Single-Use Technologies, and Annex 1

Podcasts

In this episode of the Drug Solutions Podcast, Meg Rivers, senior editor, discusses the importance of proper training for aseptic processing with Patrick Nieuwenhuizen, director senior consultant, PharmaLex.

Drug Solutions Podcast: The Criticality of Training in Aseptic Processing

Industry experts discuss the need for stricter environmental controls, whether to incorporate single-use technologies, and areas for improved automation.  

Automating Aseptic Processing Reduces Contamination Risk

ten23 health is expanding its sterile drug product manufacturing site at Visp, Switzerland to enlarge cold storage and visual inspections capacity and add clean rooms. 

ten23 health Expands its Sterile Drug Product Manufacturing Site at Visp, Switzerland

Jennifer Markarian is manufacturing reporter for Pharmaceutical Technology.

The continuous, aseptic fill/finish process is finding use in vaccines and biologic drugs. 

Considering Blow-Fill-Seal for Biologic Drugs

Moderna and Thermo Fisher Scientific have formed a collaboration to leverage dedicated commercial fill/finish manufacturing capacity in the US for mRNA vaccines and therapies.

Moderna and Thermo Fisher Scientific Form Long-Term Strategic Manufacturing Collaboration

Sartorius will invest approximately €270 million (US$305 million) to expand its biopharmaceutical manufacturing activities in South Korea’s biopharm hub.

Sartorius Launches Expansion in South Korea with Mullti-Million Dollar Investment

Global CDMO, ten23 health, has acquired filling technology and drug product manufacturing expert, swissfillon, enhancing its integrated offering.

Contract Manufacturing, Sterile, Aseptic Processing